Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06961604
EARLY_PHASE1

A Novel Method for Determination of Thromboembolic Stroke Origin

Sponsor: Atlantic Health System

View on ClinicalTrials.gov

Summary

Rupture of vulnerable carotid, vertebral, and intracranial arterial plaques results in thromboembolic stroke. Identification of these culprit lesions is an important component of post-stroke care. This study seeks to test the feasibility of NaF PET-CT to detect these plaques and alter patient care. Prior studies have shown a high degree of correlation between NaF PET+ lesions and high-risk plaque features on high resolution MRI, including mirocalcification, necrosis, and ulceration.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-06-01

Completion Date

2026-05-31

Last Updated

2025-05-08

Healthy Volunteers

No

Interventions

DRUG

NaF PET-CT

Following a non-cardiogenic thromboembolic stroke, patients will undergo NaF PET-CT imaging to identify the culprit plaque and any other vulnerable plaques at high risk for rupture

Locations (1)

Overlook Medical Center

Summit, New Jersey, United States